As of April 2, 2025, three stocks in the consumer discretionary sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices […]

Booking Holdings Inc (NASDAQ:BKNG) shares are trading lower on Monday. The company and Uber Technologies Inc (NYSE:UBER) announced a strategic global partnership. What Happened: OpenTable, part of Booking Holdings, and Uber formed a new strategic partnership, pairing Uber’s ride-hailing and delivery services with OpenTable’s restaurant network. The companies plan to work together to develop integrations […]

Braze, Inc. (NASDAQ:BRZE) posted better-than-expected fourth-quarter results after Thursday’s closing bell. Braze reported quarterly earnings of 12 cents per share, which beat the analyst consensus estimate of five cents. Quarterly revenue came in at $160.4 million, beating the $155.72 million consensus estimate. “Fiscal 2025 was a milestone year for Braze that reinforced our position as […]

On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners said he is long-term bullish but a bit nervous for the short term on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). RBC Capital analyst Brian Abrahams, on Feb. 20, maintained Vertex Pharmaceuticals with a Sector Perform rating and raised the price target from $407 to $408. Shannon […]

Bitwise Asset Management chief investment officer Matthew Hougan says the firm is “extraordinarily bullish” on Bitcoin (CRYPTO: BTC) as the cryptocurrency gains widespread acceptance from governments, corporations and traditional asset managers.  What To Know: Hougan sat down with Benzinga at the Future Proof Citywide event in Miami Beach, FL last week and talked about the […]

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Chardan Capital slashed Century Therapeutics, Inc. (NASDAQ:IPSC) price target from $11 to $7. Chardan Capital analyst Geulah Livshits maintained a Buy rating. Century Therapeutics shares […]

The Walt Disney Company (NYSE:DIS) has voted against a proposal to withdraw from a prominent LGBTQ+ rights organization’s equality ratings program. What Happened: The proposal, initiated by the right-wing think tank National Center for Public Policy Research (NCPPR) through its Free Enterprise Project (FEP) initiative, urged Disney to cease its participation in the Human Rights Campaign’s (HRC) annual Corporate Equality Index. The […]

Ripple CEO Brad Garlinghouse confirmed that the U.S. Securities and Exchange Commission will not pursue further appeals in its long-running case against the company, marking the end of a four-year legal battle. What Happened: “The case is over,” Garlinghouse announced, describing the outcome as a “victory” and labeling the SEC’s lawsuit as a failed attempt […]